Peutz-Jeghers syndrome and duodeno-jejunal adenocarcinoma - Therapeutic implications

6Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

The Peutz-Jeghers syndrome (PJS) is an autosomal dominant hamartomatous poliposis describred in 1921. Hemminki in 1997 described the presence of LKB-1 mutation tumor-suppressor gen. The patients with PJS develop a higher cumulative incidence of gastrointestinal, pancreas and extraintestinal tumors, being occasion of a renew interest on hamartomatous polyposis syndromes regarding the clinical care, cancer surveillance treatment and long term follow-up. We report the case of a 38 years old male, diagnosed of PJS who developed a multiple adenocarcinoma in duodenum and yeyunum. Surgically treated and with a long-term free disease survival of 11 years represents the sixth case reported in the spanish literature of PJS associated with a gastrointestinal tumor. A critical review, molecular alterations and the established criteria of tumor screening and surveillance are reviewed. © 2009 Arán Ediciones, S. L.

Cite

CITATION STYLE

APA

Cienfuegos, J. A., Baixauli, J., Zozaya, G., Bueno, A., Arredondo, J., Regueira, F. M., … Idoate, M. A. (2009). Peutz-Jeghers syndrome and duodeno-jejunal adenocarcinoma - Therapeutic implications. Revista Espanola de Enfermedades Digestivas, 101(12), 875–879. https://doi.org/10.4321/S1130-01082009001200009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free